James Rolke

Chief Scientific Officer, La Jolla Pharmaceutical Company.

Companies

REVELATION BIOSCIENCES, INC.Board member Jan 20, 2022 to now¹
REVELATION BIOSCIENCES, INC.Chief executive officer Jan 20, 2022 to now¹
La Jolla Pharmaceutical CompanyChief Scientific Officer Jan 6, 2017 to Jun 2, 2020²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 17, 2026Granted 208,076 shares of REVELATION BIOSCIENCES, INC.³
Apr 30, 2026Shares withheld for tax 10,115 shares at $1.13 of REVELATION BIOSCIENCES, INC.⁴
Feb 3, 2026Shares withheld for tax 8,521 shares at $1.86 of REVELATION BIOSCIENCES, INC.⁵
Jan 8, 2026Granted 532,829 shares at $0.90 of REVELATION BIOSCIENCES, INC.⁶
Oct 29, 2025Granted 390,614 shares at $1.28 of REVELATION BIOSCIENCES, INC.⁷
Feb 11, 2025Granted 30,095 shares at $3.87 of REVELATION BIOSCIENCES, INC.⁸

The numbers on this page point here. Each one links to the record it came from.